LONG-TERM DUPILUMAB MAINTAINS HISTOLOGIC AND ENDOSCOPIC IMPROVEMENTS IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: 100-WEEK RESULTS FROM THE OPEN-LABEL EXTENSION OF THE PHASE 3 EOE KIDS STUDY